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Introduction
Systemic onset Juvenile Idiopathic Artritis (sJIA) is
considered to be an autoinflammatory disease. The
S100-proteins S100A8, S100A9 and S100A12 in serum
and interleukin (IL)-18 in plasma are extremely elevated
in sJIA patients and have been proposed to be useful
biomarkers for diagnosis, disease activity and response to
therapy. Moreover, sJIA patients seem to have a defective
IL-18 NK cell axis as NK cell lytic function is impaired in
spite of high IL-18 levels. However, it is still unknown
how the inflammatory S100 proteins and IL-18 relate to
each other, and to the defective NK cell lytic function.
Objectives
Our aim is to study the relation between S100 proteins
and IL-18 in sJIA.
Methods
sJIA patients are prospectively followed and sampled
during active disease, during treatment and in remission.
Peripheral blood mononuclear cells (PBMCs) from sJIA
patients during active disease and during remission and
PBMCs from healthy controls (HCs) were stimulated
with S100A8, S100A9, S100A12 and LPS for four hours.
As a 2nd signal for NLRP3 inflammasome activation,
ATP was added during the last 30 minutes. To investi-
gate signalling pathways of the S100 proteins, TLR4 and
RAGE were blocked by adding CLI-095 and anti-RAGE
antibody, respectively. Cytokine levels in supernatant
were measured by Luminex; cell frequencies and TLR-
expression were analyzed by flow cytometry. Caspase 1-
activity was measured with a colorimetric assay (RnD).
Further, mRNA levels of NLRP3, IL-1b and IL-18 after
S100 stimulation were assessed by qPCR.
Results
Stimulation of PBMC with S100A8, S100A9 and
S100A12 resulted in cytokine production of IL-1b, IL-18
as well as IL-6 and TNF-a. The addition of ATP during
the last 30 minutes of stimulation further enhanced IL-
1b and IL-18 levels. Blocking TLR4 by adding CLI-095
decreased cytokine production to near normal levels,
while blocking RAGE did not have an effect on cytokine
production.
When compared to healthy controls, PBMCs from sJIA
patients produced less IL-18 upon S100 stimulation. The
addition of ATP enhanced this differential effect. Four
paired samples of active disease and remission were ana-
lyzed; PBMCs from active patients were less responsive to
S100 stimulation compared to PBMCs from the same
patient while in remission. There were no significant
differences in cell subset frequencies, viability of the cells
or TLR4 expression in these patients.
Conclusion
S100A8, S100A9 and S100A12 serve as a first signal to
establish NLRP3 inflammasome activation in sJIA patients
and healthy controls. This effect is TLR4-dependent.
Interestingly, S100 proteins induce less IL-1b and IL-18
production in PBMC from active sJIA patients compared
to sJIA patients in remission and healthy controls. If and
how these findings relate to involved celltypes like neutro-
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